FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MEIS2-BBS2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MEIS2-BBS2
FusionPDB ID: 52891
FusionGDB2.0 ID: 52891
HgeneTgene
Gene symbol

MEIS2

BBS2

Gene ID

4212

583

Gene nameMeis homeobox 2Bardet-Biedl syndrome 2
SynonymsCPCMR|HsT18361|MRG1BBS|RP74
Cytomap

15q14

16q13

Type of geneprotein-codingprotein-coding
Descriptionhomeobox protein Meis2Meis homolog 2Meis1, myeloid ecotropic viral integration site 1 homolog 2Meis1-related gene 1TALE homeobox protein Meis2meis1-related protein 1Bardet-Biedl syndrome 2 protein
Modification date2020031320200313
UniProtAcc

O14770

Main function of 5'-partner protein: FUNCTION: Involved in transcriptional regulation. Binds to HOX or PBX proteins to form dimers, or to a DNA-bound dimer of PBX and HOX proteins and thought to have a role in stabilization of the homeoprotein-DNA complex. Isoform 3 is required for the activity of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element; MEIS2 is not involved in complex DNA-binding. Probably in complex with PBX1, is involved in transcriptional regulation by KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation with a PBX protein (such as PBX2) is proposed to be involved in the transcriptional activation of EPHA8 in the developing midbrain. May be involved in regulation of myeloid differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the activator ACT sequence of the D(1A) dopamine receptor (DRD1) promoter and activate DRD1 transcription; isoform 5 cannot activate DRD1 transcription. {ECO:0000269|PubMed:10764806, ECO:0000269|PubMed:11279116, ECO:0000269|PubMed:21746878}.

Q9BXC9

Main function of 5'-partner protein: FUNCTION: The BBSome complex is thought to function as a coat complex required for sorting of specific membrane proteins to the primary cilia. The BBSome complex is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Firstly the BBSome associates with the ciliary membrane and binds to RAB3IP/Rabin8, the guanosyl exchange factor (GEF) for Rab8 and then the Rab8-GTP localizes to the cilium and promotes docking and fusion of carrier vesicles to the base of the ciliary membrane. The BBSome complex, together with the LTZL1, controls SMO ciliary trafficking and contributes to the sonic hedgehog (SHH) pathway regulation. Required for proper BBSome complex assembly and its ciliary localization. {ECO:0000269|PubMed:17574030, ECO:0000269|PubMed:22072986}.
Ensembl transtripts involved in fusion geneENST idsENST00000340545, ENST00000382766, 
ENST00000397620, ENST00000557796, 
ENST00000559561, ENST00000561208, 
ENST00000219869, ENST00000338564, 
ENST00000397624, ENST00000424352, 
ENST00000444725, ENST00000559085, 
ENST00000559408, 
ENST00000245157, 
ENST00000561951, ENST00000568104, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score25 X 16 X 6=24005 X 5 X 5=125
# samples 277
** MAII scorelog2(27/2400*10)=-3.15200309344505
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(7/125*10)=-0.836501267717121
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MEIS2 [Title/Abstract] AND BBS2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MEIS2 [Title/Abstract] AND BBS2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MEIS2(37242525)-BBS2(56545196), # samples:2
Anticipated loss of major functional domain due to fusion event.MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
MEIS2-BBS2 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneMEIS2

GO:0045931

positive regulation of mitotic cell cycle

26512644

HgeneMEIS2

GO:0045944

positive regulation of transcription by RNA polymerase II

10764806

HgeneMEIS2

GO:0110024

positive regulation of cardiac muscle myoblast proliferation

26512644



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr15:37242525/chr16:56545196)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MEIS2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across BBS2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000338564MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-3523142413253106593
ENST00000338564MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-3621142413253244639
ENST00000338564MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-226914244321673413
ENST00000397624MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-316310649652746593
ENST00000397624MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-326110649652884639
ENST00000397624MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-190910643511313320
ENST00000444725MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-4113201419153696593
ENST00000444725MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-4211201419153834639
ENST00000444725MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-2859201410222263413
ENST00000559085MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-316710689692750593
ENST00000559085MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-326510689692888639
ENST00000559085MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-191310681121317401
ENST00000219869MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-29508517522533593
ENST00000219869MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-30488517522671639
ENST00000219869MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-16968511411470313
ENST00000424352MEIS2chr1537242525-ENST00000568104BBS2chr1656545196-4140204119423723593
ENST00000424352MEIS2chr1537242525-ENST00000245157BBS2chr1656545196-4238204119423861639
ENST00000424352MEIS2chr1537242525-ENST00000561951BBS2chr1656545196-2886204110492290413

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000338564ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.0016995230.9983005
ENST00000338564ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0016268350.99837315
ENST00000338564ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0109829220.989017
ENST00000397624ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.001871890.9981281
ENST00000397624ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0017764320.9982236
ENST00000397624ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0047507030.9952493
ENST00000444725ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.0014087070.99859124
ENST00000444725ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0013168640.99868315
ENST00000444725ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0105189610.989481
ENST00000559085ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.0018439080.99815613
ENST00000559085ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0017529850.998247
ENST00000559085ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0196822960.9803177
ENST00000219869ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.0017955080.99820447
ENST00000219869ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0017202980.9982797
ENST00000219869ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0013593320.9986407
ENST00000424352ENST00000568104MEIS2chr1537242525-BBS2chr1656545196-0.0014605650.99853945
ENST00000424352ENST00000245157MEIS2chr1537242525-BBS2chr1656545196-0.0013542090.99864584
ENST00000424352ENST00000561951MEIS2chr1537242525-BBS2chr1656545196-0.0107828220.98921716

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MEIS2-BBS2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MEIS2chr1537242525BBS2chr16565451961064238QDTGLTILQVNNWMGQMQLCWGHWET
MEIS2chr1537242525BBS2chr1656545196106433ARHRTYNSPSKQLVADGANAIVLGTL
MEIS2chr1537242525BBS2chr16565451961068319QDTGLTILQVNNWMGQMQLCWGHWET
MEIS2chr1537242525BBS2chr1656545196106833ARHRTYNSPSKQLVADGANAIVLGTL
MEIS2chr1537242525BBS2chr1656545196142433ARHRTYNSPSKQLVADGANAIVLGTL
MEIS2chr1537242525BBS2chr16565451961424331QDTGLTILQVNNWMGQMQLCWGHWET
MEIS2chr1537242525BBS2chr1656545196201433ARHRTYNSPSKQLVADGANAIVLGTL
MEIS2chr1537242525BBS2chr16565451962014331QDTGLTILQVNNWMGQMQLCWGHWET
MEIS2chr1537242525BBS2chr1656545196204133ARHRTYNSPSKQLVADGANAIVLGTL
MEIS2chr1537242525BBS2chr16565451962041331QDTGLTILQVNNWMGQMQLCWGHWET
MEIS2chr1537242525BBS2chr165654519685133ARHRTYNSPSKQLVADGANAIVLGTL

Top

Potential FusionNeoAntigen Information of MEIS2-BBS2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MEIS2-BBS2_37242525_56545196.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MEIS2-BBS2chr1537242525chr1656545196851HLA-B08:09SPSKQLVA0.97510.558715
MEIS2-BBS2chr1537242525chr16565451961424HLA-A26:02QVNNWMGQM0.93640.5128817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A66:01QVNNWMGQM0.87150.5519817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A26:03QVNNWMGQM0.85830.6082817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A26:14QVNNWMGQM0.83340.6192817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A26:15QVNNWMGQM0.83340.6192817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A34:05QVNNWMGQM0.75970.6746817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A34:01QVNNWMGQM0.75970.6746817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A66:03QVNNWMGQM0.36740.6371817
MEIS2-BBS2chr1537242525chr16565451961424HLA-A24:17NWMGQMQLCW0.98630.85391121
MEIS2-BBS2chr1537242525chr16565451961424HLA-A31:08NWMGQMQLCW0.95050.67081121
MEIS2-BBS2chr1537242525chr1656545196851HLA-A30:08RTYNSPSKQLV0.99540.6757314
MEIS2-BBS2chr1537242525chr1656545196851HLA-B48:01KQLVADGANAI0.92750.84131021
MEIS2-BBS2chr1537242525chr1656545196851HLA-B13:02KQLVADGANAI0.88320.84271021
MEIS2-BBS2chr1537242525chr1656545196851HLA-B13:01KQLVADGANAI0.79220.99431021
MEIS2-BBS2chr1537242525chr1656545196851HLA-C06:03YNSPSKQLV0.97630.9526514
MEIS2-BBS2chr1537242525chr1656545196851HLA-A02:05LVADGANAI0.96720.86641221
MEIS2-BBS2chr1537242525chr16565451961424HLA-A26:01QVNNWMGQM0.83340.6192817
MEIS2-BBS2chr1537242525chr1656545196851HLA-B48:03KQLVADGANAI0.79920.6691021
MEIS2-BBS2chr1537242525chr1656545196851HLA-C15:05YNSPSKQLV0.9990.7557514
MEIS2-BBS2chr1537242525chr1656545196851HLA-C15:02YNSPSKQLV0.9990.7015514
MEIS2-BBS2chr1537242525chr1656545196851HLA-C06:06YNSPSKQLV0.98390.9299514
MEIS2-BBS2chr1537242525chr1656545196851HLA-C03:06LVADGANAI0.96640.99661221
MEIS2-BBS2chr1537242525chr1656545196851HLA-C06:02YNSPSKQLV0.91250.9507514
MEIS2-BBS2chr1537242525chr1656545196851HLA-C06:17YNSPSKQLV0.91250.9507514
MEIS2-BBS2chr1537242525chr16565451961424HLA-A66:02QVNNWMGQM0.41660.661817
MEIS2-BBS2chr1537242525chr1656545196851HLA-C15:02RTYNSPSKQLV0.99970.8467314
MEIS2-BBS2chr1537242525chr1656545196851HLA-A30:01RTYNSPSKQLV0.99510.7898314
MEIS2-BBS2chr1537242525chr1656545196851HLA-B40:12KQLVADGANAI0.79920.6691021

Top

Potential FusionNeoAntigen Information of MEIS2-BBS2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MEIS2-BBS2_37242525_56545196.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0301SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0303SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0305SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0305PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0305SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0307SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0310SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0310PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0310SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0313SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0315SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0318SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0320SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0322SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0324SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0324PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0326SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0326PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0326SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0328SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0330SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0332SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0334SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0336SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0338SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0338PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0338SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0338KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0338NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0340SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0340PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0340SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0342SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0342PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0342SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0342KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0344SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0346SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0348SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0350SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0352SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0354SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0422SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0422PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0434SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0466SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0472SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0704SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-0825SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1107SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1419SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1438SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1447SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1448SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1448PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1448SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1449SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1449PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1449SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1450SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1450PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1476SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1476PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1476SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1476KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1479SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1479PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1479SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1479KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1482SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1493SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1493PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1493SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1525SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1525PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1525SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB1-1525KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0101SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0101PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0101SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0101KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0101NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0104SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0104PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0104SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0104KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0104NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0105SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0105PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0105SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0105KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0105NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0108SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0108PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0108SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0108KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0108NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0109SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0109PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0109SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0109KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0109NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0111SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0111PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0111SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0111KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0111NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0112SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0112PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0112SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0112KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0112NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0113SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0113PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0113SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0113KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0113NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0114SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0114PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0114SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0114KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0114NSPSKQLVADGANAI621
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0201SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0201PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0201SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0202SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0204SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0204PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0204SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0204KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0205SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0209SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0209PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0209SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0209KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0210SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0211SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0212SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0213SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0213PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0213SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0214SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0214PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0214SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0215SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0216SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0216PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0216SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0217SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0218SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0219SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0219PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0219SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0220SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0221SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0221PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0221SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0221KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0222SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0222PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0222SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0223SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0224SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0224PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0224SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0225SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0301SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0301PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0301SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0301KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0303SKQLVADGANAIVLG924
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0303PSKQLVADGANAIVL823
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0303SPSKQLVADGANAIV722
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0303KQLVADGANAIVLGT1025
MEIS2-BBS2chr1537242525chr1656545196851DRB3-0303NSPSKQLVADGANAI621

Top

Fusion breakpoint peptide structures of MEIS2-BBS2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3812ILQVNNWMGQMQLCMEIS2BBS2chr1537242525chr16565451961424
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6385NSPSKQLVADGANAMEIS2BBS2chr1537242525chr1656545196851

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MEIS2-BBS2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3812ILQVNNWMGQMQLC-7.36978-7.48318
HLA-B14:023BVN3812ILQVNNWMGQMQLC-4.19173-5.22703
HLA-B52:013W393812ILQVNNWMGQMQLC-6.08078-7.11608
HLA-B52:013W393812ILQVNNWMGQMQLC-6.02808-6.14148
HLA-A11:014UQ23812ILQVNNWMGQMQLC-11.396-11.5094
HLA-A24:025HGA3812ILQVNNWMGQMQLC-5.5142-6.5495
HLA-A24:025HGA3812ILQVNNWMGQMQLC-5.43263-5.54603
HLA-B27:056PYJ3812ILQVNNWMGQMQLC-5.93836-6.05176
HLA-B44:053DX83812ILQVNNWMGQMQLC-5.39102-5.50442
HLA-B44:053DX83812ILQVNNWMGQMQLC-4.5657-5.601
HLA-B14:023BVN6385NSPSKQLVADGANA-7.15543-7.26883
HLA-B14:023BVN6385NSPSKQLVADGANA-4.77435-5.80965
HLA-B52:013W396385NSPSKQLVADGANA-6.80875-6.92215
HLA-B52:013W396385NSPSKQLVADGANA-4.20386-5.23916
HLA-A11:014UQ26385NSPSKQLVADGANA-7.5194-8.5547
HLA-A11:014UQ26385NSPSKQLVADGANA-6.9601-7.0735
HLA-A24:025HGA6385NSPSKQLVADGANA-7.52403-7.63743
HLA-A24:025HGA6385NSPSKQLVADGANA-5.82433-6.85963
HLA-B27:056PYJ6385NSPSKQLVADGANA-3.28285-4.31815
HLA-B44:053DX86385NSPSKQLVADGANA-5.91172-6.94702
HLA-B44:053DX86385NSPSKQLVADGANA-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of MEIS2-BBS2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MEIS2-BBS2chr1537242525chr16565451961021KQLVADGANAIAAACAACTGGTAGCAGATGGGGCAAATGCAATT
MEIS2-BBS2chr1537242525chr16565451961121NWMGQMQLCWCAACTGGATGGGGCAAATGCAATTGTGCTG
MEIS2-BBS2chr1537242525chr16565451961221LVADGANAICTGGTAGCAGATGGGGCAAATGCAATT
MEIS2-BBS2chr1537242525chr1656545196314RTYNSPSKQLVAGGACTTACAATTCTCCAAGTAAACAACTGGTA
MEIS2-BBS2chr1537242525chr1656545196514YNSPSKQLVTACAATTCTCCAAGTAAACAACTGGTA
MEIS2-BBS2chr1537242525chr1656545196715SPSKQLVATCTCCAAGTAAACAACTGGTAGCA
MEIS2-BBS2chr1537242525chr1656545196817QVNNWMGQMCCAAGTAAACAACTGGATGGGGCAAAT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MEIS2-BBS2chr1537242525chr16565451961025KQLVADGANAIVLGTAAACAACTGGTAGCAGATGGGGCAAATGCAATTGTGCTGGGGACA
MEIS2-BBS2chr1537242525chr1656545196621NSPSKQLVADGANAIAATTCTCCAAGTAAACAACTGGTAGCAGATGGGGCAAATGCAATT
MEIS2-BBS2chr1537242525chr1656545196722SPSKQLVADGANAIVTCTCCAAGTAAACAACTGGTAGCAGATGGGGCAAATGCAATTGTG
MEIS2-BBS2chr1537242525chr1656545196823PSKQLVADGANAIVLCCAAGTAAACAACTGGTAGCAGATGGGGCAAATGCAATTGTGCTG
MEIS2-BBS2chr1537242525chr1656545196924SKQLVADGANAIVLGAGTAAACAACTGGTAGCAGATGGGGCAAATGCAATTGTGCTGGGG

Top

Information of the samples that have these potential fusion neoantigens of MEIS2-BBS2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCMEIS2-BBS2chr1537242525ENST00000219869chr1656545196ENST00000245157TCGA-WP-A9GB-01A
SARCMEIS2-BBS2chr1537242525ENST00000338564chr1656545196ENST00000561951TCGA-WP-A9GB-01A

Top

Potential target of CAR-T therapy development for MEIS2-BBS2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MEIS2-BBS2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MEIS2-BBS2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource